Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
Appointed director
Cascadian Therapeutics, Inc. (CASC) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/09/2018 SC 13G/A Baupost Group reports a 0% stake in Cascadian Therapeutics, Inc.
02/13/2018 SC 13G/A Baupost Group reports a 17.2% stake in Cascadian Therapeutics, Inc.
02/06/2018 SC 13G/A FRANKLIN RESOURCES INC reports a 0% stake in CASCADIAN THERAPEUTICS, INC.
02/08/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
10/29/2013 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
08/06/2013 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
06/07/2013 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
04/05/2012 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/14/2012 SC 13G/A Oncothyreon Inc. reports a 7.3% stake in Oncothyreon Inc.
02/12/2010 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy